University of Pittsburgh Health Sciences eLearning Environment Internet-based Studies in Education and Research
INTRODUCTION
ABIM MOC Activity ID
3/8/2022 - Medical Grand Rounds: ID COVID-19 Update
QUIZ
EVALUATION
CERTIFICATE
Credit Hours: CME 1.00
Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.
Upon completion of this activity, participants should be able to:
- Describe the antivirals that treat COVID-19
- Evaluate the efficacy of antivirals that treat COVID-19
- Discuss NIH recommendations for COVID-19 therapy
- Discuss the new CDC COVID community levels
- Employ recommended PPE guidance for COVID-19 from the CDC
- Implement newest COVID-19n prevent research in hospitals
- Describe current landscape of monoclonal antibodies for treatment of Covid-19
- Discuss use of monoclonal antibody therapy for prevention of Covid-19
- Determine role in therapy of monoclonal antibodies for patients with Covid-19
Abstract
Dr. Elise Martin, Dr. Erin McCreary, and Dr. Ghady Haidar, will discuss the most up-to-date epidemiologic trends in COVID-19 in our region, the most recent data regarding monoclonal antibodies, and data for antiviral therapeutics. Please join us for what promises to be a very interesting and informative hour.
Joint Accreditation Statement

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Suggested Additional Reading:
NIH Covid-19 guidelines: https://www.covid19treatmentguidelines.nih.gov/
IDSA Covid-19 guidelines: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/
SIDP Monoclonal antibody toolkit: https://sidp.org/COVID19-Monoclonal-Antibody-Toolkit-Guide
CDC Community levels: https://www.cdc.gov/coronavirus/2019-ncov/downloads/science/Scientific-Rationale-summary-COVID-19-Community-Levels.pdf
CDC Transmission Risk: https://covid.cdc.gov/covid-data-tracker/#datatracker-home
Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection — California, February–December 2021 https://www.cdc.gov/mmwr/volumes/71/wr/mm7106e1.htm
https://www.covid19treatmentguidelines.nih.gov
This activity is approved for AMA PRA Category 1 Credit™
The University of Pittsburgh is an affirmative action, equal opportunity institution.